1. Home
  2. Analysis
  3. Tresiba
  4. Humalog

Tresiba vs. Humalog: side effect and effectiveness comparison (a real world drug study)

Summary:

We compare the side effects and drug effectiveness of Tresiba and Humalog. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 154,501 people who take Tresiba and Humalog, and is updated regularly.

What is Tresiba?

Tresiba has active ingredients of insulin degludec. It is often used in type 1 diabetes. eHealthMe is studying from 20,677 Tresiba users. Check the latest studies of Tresiba.

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.

On Jun, 18, 2026

154,501 people who take Tresiba and Humalog are studied.

Tresiba vs Humalog drug comparison reports.

Drugs being compared in this study:

  • Humalog (insulin lispro recombinant)
  • Tresiba (insulin degludec)

Most common side effects of the drugs, overall:

Click here to view

Most common side effects of the drugs, in long term (1+ years) use:

Click here to view

Drug effectiveness:

Tresiba:

  • not at all: 2.94 %
  • somewhat: 9.41 %
  • moderate: 36.47 %
  • high: 30.0 %
  • very high: 21.18 %

Humalog:

  • not at all: 0.63 %
  • somewhat: 7.95 %
  • moderate: 20.71 %
  • high: 40.38 %
  • very high: 30.33 %

Want to compare Tresiba with Humalog?

- Personalize this study to your gender and age (0-99+)

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Browse all side effects of Tresiba:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Humalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study is based on insulin degludec and insulin lispro recombinant (the active ingredients of Tresiba and Humalog, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.